{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:32:42Z","timestamp":1772890362645,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,1,12]],"date-time":"2011-01-12T00:00:00Z","timestamp":1294790400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The anti-HCV antibody response has not been well characterized during the early phase of HCV infection and little is known about its relationship to the clinical course during this period.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We analyzed serial anti-HCV antibodies longitudinally obtained from a prospective cohort of 65 patients with acute HCV infection by using a microparticle enzyme immunoassay AxSYM HCV 3.0 (Abbott Diagnostics) during the first 12 months from HCV acquisition in Rio de Janeiro, Brazil. Spontaneous viral clearance (SVC) was defined as undetectable HCV RNA in serum, in the absence of treatment, for three consecutive HCV PCR tests within 12-months of follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Baseline antibody values were similar among patient groups with self-limiting HCV evolution (n = 34) and persistent viremia (n = 31) [median (interquartile range) signal\/cut-off ratio (s\/co) 78.7 (60.7-93.8) vs. 93.9 (67.8-111.9), p = 0.26]. During 12-months follow-up, patients with acute spontaneous resolving HCV infection showed significantly lower serial antibody response in comparison to individuals progressing to chronic infection [median (interquartile range) s\/co 62.7 (35.2-85.0) vs. 98.4 (70.4-127.4), p &lt; 0.0001]. In addition, patients with self-limiting HCV evolution exhibited an expeditious, sharp decline of serial antibody values after SVC in comparison to those measured before SVC [median (interquartile range) s\/co 56.0 (25.4-79.3) vs. 79.4 (66.3-103.0), p &lt; 0.0001].<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our findings indicate a rapid short-term decline of antibody values in patients with acute spontaneous resolving HCV infection.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2334-11-15","type":"journal-article","created":{"date-parts":[[2011,1,19]],"date-time":"2011-01-19T11:08:41Z","timestamp":1295435321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Antibody dynamics and spontaneous viral clearance in patients with acute hepatitis C infection in Rio de Janeiro, Brazil"],"prefix":"10.1186","volume":"11","author":[{"given":"Alexander M","family":"Strasak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur Y","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg M","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo S","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cleber F","family":"Ginuino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos E","family":"Velloso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adilson J","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaqueline M","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara F","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian Schulze","family":"zur Wiesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gl\u00e1ucia","family":"Paranhos-Baccal\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry J","family":"Brant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanno","family":"Ulmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Strohmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalit","family":"Kaltenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Lampe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lia L","family":"Lewis-Ximenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,12]]},"reference":[{"key":"1358_CR1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0016-5085(03)00668-1","volume":"125","author":"JT Gerlach","year":"2003","unstructured":"Gerlach JT, Diepolder HM, Zachoval R, Gruener NH, Jung MC, Ulsenheimer A, Schraut WW, Schirren CA, Waechtler M, Backmund M, Pape GR: Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology. 2003, 125: 80-88. 10.1016\/S0016-5085(03)00668-1.","journal-title":"Gastroenterology"},{"key":"1358_CR2","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.cgh.2006.06.026","volume":"4","author":"KE Corey","year":"2006","unstructured":"Corey KE, Ross AS, Wurcel A, Schulze Zur Wiesch J, Kim AY, Lauer GM, Chung RT: Outcomes and treatment of acute hepatitis C virus infection in a United States population. Clin Gastroenterol Hepatol. 2006, 4: 1278-1282. 10.1016\/j.cgh.2006.06.026.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1358_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/0091270003258669","volume":"44","author":"The Global Burden of Hepatitis C Working Group","year":"2004","unstructured":"The Global Burden of Hepatitis C Working Group: Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol. 2004, 44: 20-29. 10.1177\/0091270003258669.","journal-title":"J Clin Pharmacol"},{"key":"1358_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(08)61116-2","volume":"372","author":"A Maheshwari","year":"2008","unstructured":"Maheshwari A, Ray S, Thuluvath PJ: Acute hepatitis C. Lancet. 2008, 372: 321-332. 10.1016\/S0140-6736(08)61116-2.","journal-title":"Lancet"},{"key":"1358_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cld.2005.05.003","volume":"9","author":"DL Thomas","year":"2005","unstructured":"Thomas DL, Seeff LB: Natural history of hepatitis C. Clin Liver Dis. 2005, 9: 383-398. 10.1016\/j.cld.2005.05.003.","journal-title":"Clin Liver Dis"},{"key":"1358_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","volume":"13","author":"JM Micallef","year":"2006","unstructured":"Micallef JM, Kaldor JM, Dore GJ: Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies. J Viral Hepat. 2006, 13: 34-41. 10.1111\/j.1365-2893.2005.00651.x.","journal-title":"J Viral Hepat"},{"key":"1358_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1053\/jhep.2003.50019","volume":"37","author":"H Hofer","year":"2003","unstructured":"Hofer H, Watkins-Riedel T, Janata O, Penner E, Holzmann H, Steindl-Munda P, Gangl A, Ferenci P: Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load. Hepatology. 2003, 37: 60-64. 10.1053\/jhep.2003.50019.","journal-title":"Hepatology"},{"key":"1358_CR8","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1056\/NEJMoa011232","volume":"345","author":"E Jaeckel","year":"2001","unstructured":"Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, Pastore G, Dietrich M, Trautwein C, Manns MP, German Acute Hepatitis C Therapy Group: Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med. 2001, 345: 1452-1457. 10.1056\/NEJMoa011232.","journal-title":"N Engl J Med"},{"key":"1358_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/hep.21902","volume":"47","author":"JT Blackard","year":"2008","unstructured":"Blackard JT, Shata MT, Shire NJ, Sherman KE: Acute hepatitis C virus infection: a chronic problem. Hepatology. 2008, 47: 321-331. 10.1002\/hep.21902.","journal-title":"Hepatology"},{"key":"1358_CR10","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1086\/522608","volume":"196","author":"CC Wang","year":"2007","unstructured":"Wang CC, Krantz E, Klarquist J, Krows M, McBride L, Scott EP, Shaw-Stiffel T, Weston SJ, Thiede H, Wald A, Rosen HR: Acute hepatitis C in a contemporary US cohort: Modes of acquisition and factors influencing viral clearance. J Infect Dis. 2007, 196: 1474-1482. 10.1086\/522608.","journal-title":"J Infect Dis"},{"issue":"12","key":"1358_CR11","doi-asserted-by":"publisher","first-page":"e4085","DOI":"10.1371\/journal.pone.0004085","volume":"3","author":"N Sharaf Eldin","year":"2008","unstructured":"Sharaf Eldin N, Ismail S, Mansour H, Rekacewicz C, El-Houssinie M, El-Kafrawy S, El Aidi S, Abdel-Hamid M, Esmat G, Pol S, Fontanet A, Mohamed MK: Symptomatic acute hepatitis C in Egypt: diagnosis, spontaneous viral clearance, and delayed treatment with 12 weeks of pegylated interferon alfa-2a. PLoS One. 2008, 3 (12): e4085-10.1371\/journal.pone.0004085.","journal-title":"PLoS One"},{"key":"1358_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1053\/j.gastro.2008.11.049","volume":"136","author":"AL Cox","year":"2009","unstructured":"Cox AL, Page K, Bruneau J, Shoukry NH, Lauer GM, Kim AY, Rosen HR, Radziewicz H, Grakoui A, Fierer DS, Branch AD, Kaplan DE, Chang KM: Rare birds in North America: acute hepatitis C cohorts. Gastroenterology. 2009, 136: 26-31. 10.1053\/j.gastro.2008.11.049.","journal-title":"Gastroenterology"},{"key":"1358_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/75063","volume":"6","author":"A Takaki","year":"2000","unstructured":"Takaki A, Wiese M, Maertens G, Depla E, Seifert U, Liebetrau A, Miller JL, Manns MP, Rehermann B: Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med. 2000, 6: 578-582. 10.1038\/75063.","journal-title":"Nat Med"},{"key":"1358_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1053\/jhep.2001.22112","volume":"33","author":"JR Orland","year":"2001","unstructured":"Orland JR, Wright TL, Cooper S: Acute hepatitis C. Hepatology. 2001, 33: 321-327. 10.1053\/jhep.2001.22112.","journal-title":"Hepatology"},{"key":"1358_CR15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1086\/432478","volume":"41","author":"DM Netski","year":"2005","unstructured":"Netski DM, Mosbruger T, Depla E, Maertens G, Ray SC, Hamilton RG, Roundtree S, Thomas DL, McKeating J, Cox A: Humoral immune response in acute hepatitis C virus infection. Clin Infect Dis. 2005, 41: 667-675. 10.1086\/432478.","journal-title":"Clin Infect Dis"},{"key":"1358_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0016-5085(99)70237-4","volume":"116","author":"M Chen","year":"1999","unstructured":"Chen M, S\u00e4llberg M, S\u00f6nnerborg A, Weiland O, Mattsson L, Jin L, Birkett A, Peterson D, Milich DR: Limited humoral immunity in hepatitis C virus infection. Gastroenterology. 1999, 116: 135-143. 10.1016\/S0016-5085(99)70237-4.","journal-title":"Gastroenterology"},{"key":"1358_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1055\/s-2005-864778","volume":"25","author":"T Heller","year":"2005","unstructured":"Heller T, Rehermann B: Acute hepatitis C: a multifaceted disease. Semin Liver Dis. 2005, 25: 7-17. 10.1055\/s-2005-864778.","journal-title":"Semin Liver Dis"},{"key":"1358_CR18","doi-asserted-by":"publisher","first-page":"10149","DOI":"10.1073\/pnas.0403519101","volume":"101","author":"C Logvinoff","year":"2004","unstructured":"Logvinoff C, Major ME, Oldach D, Heyward S, Talal A, Balfe P, Feinstone SM, Alter H, Rice CM, McKeating JA: Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci USA. 2004, 101: 10149-10154. 10.1073\/pnas.0403519101.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1358_CR19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1046\/j.1365-2893.2002.00369.x","volume":"9","author":"LI Nikolaeva","year":"2002","unstructured":"Nikolaeva LI, Blokhina NP, Tsurikova NN, Voronkova NV, Miminoshvili MI, Braginsky DM, Yastrebova ON, Booynitskaya OB, Isaeva OV, Michailov MI, Archakov AI: Virus-specific antibody titers in different phases of hepatitis C virus infection. J Viral Hepat. 2002, 9: 429-437. 10.1046\/j.1365-2893.2002.00369.x.","journal-title":"J Viral Hepat"},{"key":"1358_CR20","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1086\/651599","volume":"50","author":"LL Lewis-Ximenez","year":"2010","unstructured":"Lewis-Ximenez LL, Lauer GM, Schulze Zur Wiesch J, de Sousa PS, Ginuino CF, Paranhos-Baccal\u00e1 G, Ulmer H, Pfeiffer KP, Goebel G, Pereira JL, Mendes de Oliveira J, Yoshida CF, Lampe E, Velloso CE, Alves Pinto M, Coelho HS, Almeida AJ, Fernandes CA, Kim AY, Strasak AM: Prospective Follow-Up of Patients with Acute Hepatitis C Virus Infection in Brazil. Clin Infect Dis. 2010, 50: 1222-1230. 10.1086\/651599.","journal-title":"Clin Infect Dis"},{"key":"1358_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1017\/S0950268806006388","volume":"135","author":"J Amin","year":"2007","unstructured":"Amin J, Law MG, Micallef J, Jauncey M, Van Beek I, Kaldor JM, Dore GJ: Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users. Epidemiol Infect. 2007, 135: 144-150. 10.1017\/S0950268806006388.","journal-title":"Epidemiol Infect"},{"key":"1358_CR22","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1086\/428578","volume":"40","author":"AL Cox","year":"2005","unstructured":"Cox AL, Netski DM, Mosbruger T, Sherman SG, Strathdee S, Ompad D, Vlahov D, Chien D, Shyamala V, Ray SC, Thomas DL: Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis. 2005, 40: 951-958. 10.1086\/428578.","journal-title":"Clin Infect Dis"},{"key":"1358_CR23","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1086\/605561","volume":"49","author":"BH McGovern","year":"2009","unstructured":"McGovern BH, Birch CE, Bowen MJ, Reyor LL, Nagami EH, Chung RT, Kim AY: Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria. Clin Infect Dis. 2009, 49: 1051-1060. 10.1086\/605561.","journal-title":"Clin Infect Dis"},{"key":"1358_CR24","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1046\/j.1365-2516.2001.00559.x","volume":"7","author":"K Messick","year":"2001","unstructured":"Messick K, Sanders JC, Goedert JJ, Eyster ME: Hepatitis C viral clearance and antibody reactivity patterns in persons with haemophilia and other congenital bleeding disorders. Haemophilia. 2001, 7: 568-574. 10.1046\/j.1365-2516.2001.00559.x.","journal-title":"Haemophilia"},{"key":"1358_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1365-2893.2004.00533.x","volume":"11","author":"SN Lu","year":"2004","unstructured":"Lu SN, Tung HD, Chen TM, Lee CM, Wang JH, Hung CH, Chen CH, Changchien CS: Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titre rather than by seroconversion?. J Viral Hepat. 2004, 11: 563-570. 10.1111\/j.1365-2893.2004.00533.x.","journal-title":"J Viral Hepat"},{"key":"1358_CR26","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/infdis\/175.2.316","volume":"175","author":"JJ Lefr\u00e8re","year":"1997","unstructured":"Lefr\u00e8re JJ, Guiramand S, Lefr\u00e8re F, Mariotti M, Aumont P, Lerable J, Petit JC, Girot R, Morand-Joubert L: Full or partial seroreversion in patients infected by hepatitis C virus. J Infect Dis. 1997, 175: 316-322.","journal-title":"J Infect Dis"},{"key":"1358_CR27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S0042-6822(03)00461-6","volume":"314","author":"MT Shata","year":"2003","unstructured":"Shata MT, Tricoche N, Perkus M, Tom D, Brotman B, McCormack P, Pfahler W, Lee DH, Tobler LH, Busch M, Prince AM: Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees. Virology. 2003, 314: 601-616. 10.1016\/S0042-6822(03)00461-6.","journal-title":"Virology"},{"key":"1358_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jcv.2003.08.007","volume":"30","author":"V Bossi","year":"2004","unstructured":"Bossi V, Galli C: Quantitative signal of anti-HCV by an automated assay predicts viremia in a population at high prevalence of hepatitis C virus infection. J Clin Virol. 2004, 30: 45-49. 10.1016\/j.jcv.2003.08.007.","journal-title":"J Clin Virol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-11-15\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:46:05Z","timestamp":1630503965000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-11-15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,12]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1358"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-11-15","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,12]]},"assertion":[{"value":"22 July 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"15"}}